← Leaderboards
Frank D. McKeon
University Of Houston
$18,999,261
Attributed
$21,694,144
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,694,144 · 12
By mechanism
R01$19,219,494 · 9
U24$1,029,600 · 1
RC1$993,625 · 1
R21$451,425 · 1
Top collaborators
- Jaffer A. Ajani4 shared
- Wa Xian4 shared
- Christopher Paul Crum2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCarcinogenesisStem CellsGene ExpressionPharmaceutical PreparationsLaboratory MouseInsightLinkLibrariesTechnologyCloningGenesGeneticBarrett EsophagusChronicDrug DiscoveryNeoplasm /Cancer GeneticsResponseTumorEsophageal AdenocarcinomaLesionMutationDysplasiaClone Cells
Grant awards (52)
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma$949,184
R01 · FY2025 · CA · contact PI
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis$678,096
R01 · FY2025 · HL · contact PI
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma$888,662
R01 · FY2024 · CA · contact PI
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis$664,534
R01 · FY2024 · HL · contact PI
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma$916,726
R01 · FY2023 · CA · contact PI
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis$678,096
R01 · FY2023 · HL · contact PI
Clonal Reconstruction and Targeting of the Correa Sequence$550,822
R01 · FY2023 · CA · contact PI
Common Stem Cell of Origin for Junctional and Gastric Adenocarcinoma$949,184
R01 · FY2022 · CA · contact PI
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis$691,846
R01 · FY2022 · HL · contact PI
Clonal Reconstruction and Targeting of the Correa Sequence$550,821
R01 · FY2022 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$135,000
U24 · FY2022 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$180,000
U24 · FY2021 · CA · contact PI
Clonal Reconstruction and Targeting of the Correa Sequence$1
R01 · FY2021 · CA · contact PI
Clonal Reconstruction and Targeting of the Correa Sequence$561,961
R01 · FY2020 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$180,000
U24 · FY2020 · CA · contact PI
Clonal Reconstruction and Targeting of the Correa Sequence$601,106
R01 · FY2019 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$174,600
U24 · FY2019 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$180,000
U24 · FY2018 · CA · contact PI
Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence$180,000
U24 · FY2017 · CA · contact PI
The squamocolumnar junction and cervical cancer$192,428
R21 · FY2014 · CA
The squamocolumnar junction and cervical cancer$258,997
R21 · FY2013 · CA
Epithelial Stem Cell Programs$373,786
R01 · FY2011 · GM · contact PI
Monoclonal Antibodies and Genetic Elements for Airway Disease$493,625
RC1 · FY2010 · HL · contact PI
p63-Dependent Checkpoints in Oocytes$489,014
R01 · FY2010 · HD · contact PI
Epithelial Stem Cell Programs$377,561
R01 · FY2010 · GM · contact PI
Monoclonal Antibodies and Genetic Elements for Airway Disease$500,000
RC1 · FY2009 · HL · contact PI
p63-Dependent Checkpoints in Oocytes$484,670
R01 · FY2009 · HD · contact PI
Epithelial Stem Cell Programs$381,282
R01 · FY2009 · GM · contact PI
Epithelial Stem Cell Programs$380,250
R01 · FY2008 · GM · contact PI
Murine p73 in Tumorigenesis$377,685
R01 · FY2007 · CA · contact PI
Murine p73 in Tumorigenesis$388,964
R01 · FY2006 · CA · contact PI
Mitotic Checkpoint Proteins in Tumorigenesis$369,143
R01 · FY2006 · CA · contact PI
Murine p73 in Tumorigenesis$398,325
R01 · FY2005 · CA
Mitotic Checkpoint Proteins in Tumorigenesis$378,028
R01 · FY2005 · CA
Control of NF-AT Signaling Through Nuclear Import$275,200
R01 · FY2005 · GM
Murine p73 in Tumorigenesis$397,738
R01 · FY2004 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$396,897
R01 · FY2004 · CA
Mitotic Checkpoint Proteins in Tumorigenesis$378,028
R01 · FY2004 · CA
Control of NF-AT Signaling Through Nuclear Import$275,200
R01 · FY2004 · GM
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$385,337
R01 · FY2003 · CA
Mitotic Checkpoint Proteins in Tumorigenesis$378,028
R01 · FY2003 · CA
Murine p73 in Tumorigenesis$372,508
R01 · FY2003 · CA
Control of NF-AT Signaling Through Nuclear Import$326,800
R01 · FY2003 · GM
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$559,874
R01 · FY2002 · CA
Mitotic Checkpoint Proteins in Tumorigenesis$353,143
R01 · FY2002 · CA
Control of NF-AT Signaling Through Nuclear Import$293,765
R01 · FY2002 · GM
MURINE P73 IN TUMORIGENESIS$38,823
R01 · FY2002 · CA
MURINE P73 IN TUMORIGENESIS$439,844
R01 · FY2001 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$363,219
R01 · FY2001 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$108,360
R01 · FY2001 · CA
MURINE P73 IN TUMORIGENESIS$427,110
R01 · FY2000 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION$369,873
R01 · FY2000 · CA